by Dr. Vikram Venkateswaran
In the realm of Generative AI (Gen AI), the healthcare industry is on the verge of transformative changes that promise to reshape the delivery of care. Within this paradigm shift, one critical aspect demanding attention is the role of cybersecurity controls.
In a recent announcement, Paul McCartney, the last surviving Beatle, declared that the group would release a ‘final’ Beatles song1. This news garnered significant attention, given that the other band members have passed away. What we now know is that Gen AI will be used to create the song based on unreleased recordings of the lead singer, John Lennon. This showcases the power of Gen AI and the potential of this emerging technology.
While music has a huge impact on health, the Life Sciences and Health Care (LSHC) industry is not very far behind in its adoption of Gen AI. In life sciences, Gen AI is poised to develop drug candidates, screen potential therapies, and then map their impact even before clinical trials.This approach will ensure a reduction in the time spent on drug discovery and the thorough assessment of the efficacy and toxicity of drug…
